Filing Details

Accession Number:
0001209191-15-079483
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-12 07:36:47
Reporting Period:
2015-11-11
Filing Date:
2015-11-12
Accepted Time:
2015-11-12 07:36:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542052 Susan Hall C/O Endo International Plc
Minerva House, Simmonscourt Road
Ballsbridge, Dublin 4 L2 00000
Evp, Cso, Global Head Of R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-11-11 1,000 $55.35 2,666 No 4 P Direct
Stock Incentive Plan Performance Shares Acquisiton 2015-11-11 1,000 $0.00 13,740 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Stock Incentive Plan Restricted Stock Units (Rsu) 7,515 Direct
Footnotes
  1. The performance shares vest upon the Company achieving certain shareholder return targets over a cumulative 3-year period.
  2. Represents the target number of shares issuable upon achievement of a certain shareholder return target over a cumulative 3-year period, as determined by the Registrant's Board of Directors at the end of such three-year period. The ultimate number of shares issued may be the target number or zero, depending on the Registrant's attainment of the shareholder return target over the period.
  3. Pursuant to the Endo International plc Matched Performance Share Unit Program, the Registrant matched Ms. Hall's open market purchases of ordinary shares, subject to certain limitations, which occurred on November 11, 2015, as reported above. These securities were granted to Ms. Hall in consideration of her services as the Executive Vice President, Chief Scientific Officer, Global Head of R&D of Endo International plc.
  4. Represents the cumulative target quantity of shares issuable with respect to all 2010 and 2015 Stock Incentive Plan performance shares outstanding. The cumulative total is the combination of the target payouts for the current grant and all past grants made under the 2010 Stock Incentive Plan and the 2015 Stock Incentive Plan and still outstanding, which are subject to a range of payouts depending on the achievement of certain performance metrics as described herein for the current grant and as previously disclosed for all other performance share grants.
  5. Subject to time-based vesting, each restricted stock automatically converts into one (1) ordinary share of Endo International plc.